You are here: Industry Insights > metabolic disease

News List

Sciwind Biosciences Announces Initiation of Patient Dosing in Phase 2b Clinical Trial Evaluating XW003, its Lead GLP-1 Drug Candidate, for the Treatment of Obesity prnasia
January 18, 2022
Sciwind Biosciences Co., Ltd., a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapies to treat metabolic disease, today announced the initiation of patient dosing...
SmartZyme spins off protein tech company for a metabolic disease partnership with Hemoshear fiercebiotech
January 02, 2019
SmartZyme BioPharma is spinning off its protein-based therapeutic platform into a new company—dubbed Carnot BioSciences—as part of a collaboration with Hemoshear Therapeutics aimed at rare metabolic diseases.....
Embark and Novo Nordisk enter collaboration to discover novel therapeutics for obesity and metabolic disease worldpharmanews
November 10, 2018
Embark Biotech ApS and Novo Nordisk A/S have entered into a research collaboration focusing on the discovery of novel treatments for obesity and its associated metabolic pathologies through mechanisms that increase energy expenditure.
Embark and Novo Nordisk enter collaboration to discover novel therapeutics for obesity and metabolic disease worldpharmanews
November 10, 2018
Embark Biotech ApS and Novo Nordisk A/S have entered into a research collaboration focusing on the discovery of novel treatments for obesity and its associated metabolic pathologies through mechanisms that increase energy expenditure.
Evotec and Eternygen to Develop Metabolic Disease Therapy contractpharma
January 11, 2017
Evotec AG is extending its existing relationship with Eternygen GmbH by becoming an investor in addition to being a pre-clinical drug discovery partner.